Fidaxomicin

Restricted
C. diff Risk

None

Oral Bioavailability

None

Spectrum Of Activity

Dosing

200mg po BID x 10days for C. difficile

No adjustment

No adjustment

General Information

Hypersensitivity: facial, tongue, or throat swelling

GI disturbance, cytopenias

  • Consult Infectious Disease

  • Non-formulary

  • Minimal systemic absorption

Antimicrobial class: Specialized anti-C. diffile macrocyclic agent

Pregnancy category: B

Average serum half life: 0.0

Biliary penetration: None

CSF penetration: None

Lung penetration: None

Urine penetration: None

C. difficile colitis